Search

• Actinidia arguta is a source of bioactive compounds for food industry. • Bioactive compounds from A. arguta are reviewed. • A. arguta has high nutritional, functional and economic value. • Health promoting effects of A. arguta have been confirmed in vitro and in vivo. • A. arguta can be used in the prevention/treatment of chronic diseases (e.g. diabetes). Hardy kiwi (Actinidia arguta) is a climbing, perennial and dioecious vine from Actinidiaceae family, native from Asia and valued as ornamental and traditional medicine. In the last decade, the growing interest as fruit-bearing plant encourage the expanding cultivation of A. arguta mainly to fruits production, particularly in Europe and North America. A. arguta plants have an extensive range of bioactive compounds that can be obtained from different botanical structures, such as fruits, leaves, flowers and stems. These bioactive molecules, with well-recognized health-promoting properties, include phenolic compounds, minerals, carbohydrates or even volatile substances, with a great potential to be used in several formulations of food products. Phytochemical studies on this plant reported hypoglycemic effects as well as antioxidant and anti-inflammatory activities, among others. The traditional uses of A. arguta have been experimentally proved by in vitro and in vivo studies, in which its bioactivities were associated to its phytochemical composition. This review aims to assess and summarize the phytochemical and healthy properties of the different botanical parts of A. arguta , describing their bioactive composition and exploring it potential functional properties on foodstuffs. [ABSTRACT FROM AUTHOR]

• Optimization of UAE with single-factor experiments and response surface methodology • Optimal extract obtained with 50% water, 50% amplitude in 17.5 min • Identification of polyphenols by HPLC-ESI-QTOF-MS • Optimal extract exhibited stronger antimicrobial and anticancer activities Actinidia arguta fruit (also known as kiwiberry) has a remarkable phytochemical profile, being reported as a promising preventive agent/treatment for chronic diseases and a desirable source of bioactive molecules for pharmaceutical and cosmetic industries. Despite these promising indications, investigating the full potential of A. arguta fruit remains an unmet need for health applications. This work aims to determine the optimal extraction conditions of antioxidant/antiradical compounds from A. arguta fruit (commonly known as kiwiberry), using the Response Surface Methodology (RSM). The effects of probe amplitude (30%-70%), sonication time (5-30 min) and water:ethanol solvent ratio (0%-100%) were assessed. The optimal extraction conditions were achieved using 50% of water, during 17.5 min and using an amplitude of 50%. A total of 22 compounds, including 6 flavonoids and 4 phenolic acids, were identified in the optimal extract through HPLC-ESI-QTOF-MS, which exhibited outstanding antioxidant and antiradical activities (TPC = 18.705 mg GAE/g dw; FRAP = 186.876 µmol FSE/g dw; ABTS = 16.334 mg AAE/g dw; O 2 ·− IC 50 = 829.384 µg/mL; HOCl IC 50 = 16.895 µg/mL; ROO· = 0.18 µg TE/mg dw). Moreover, it displayed antimicrobial activity against Staphylococcus aureus (MIC = 32 mg/mL) and Pseudomonas gingivalis (MIC = 64 mg/mL) and reduced the growth rate of Escherichia coli. In-vitro assays demonstrated that the optimal extract successfully decreased the viability of two human carcinoma cell lines, namely TR146 and HSC-3, at 500 µg/mL and above 500 µg/mL, respectively. The present study showed that A. arguta fruit is a rich source of compounds with potential to be used for pro-healthy purposes. [Display omitted] [ABSTRACT FROM AUTHOR]